Articles with "tyk2" as a keyword



Photo from wikipedia

Association of germline TYK2 variation with lung cancer and non‐Hodgkin lymphoma risk

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Cancer"

DOI: 10.1002/ijc.34180

Abstract: Deucravacitinib, a novel, selective inhibitor of TYK2 is currently under review at the FDA and EMA for treatment of moderate‐to‐severe plaque psoriasis. It is unclear whether recent safety concerns (ie, elevated rates of lung cancer… read more here.

Keywords: lung cancer; tyk2; lymphoma; risk ... See more keywords
Photo by tcwillmott from unsplash

Comprehensive assessment of the association between genes on JAK-STAT pathway (IFIH1, TYK2, IL-10) and systemic lupus erythematosus: a meta-analysis

Sign Up to like & get
recommendations!
Published in 2018 at "Archives of Dermatological Research"

DOI: 10.1007/s00403-018-1858-0

Abstract: Previous studies have reported that genes relating to JAK-STAT pathway (IFIH1, TYK2 and IL-10) conferred the susceptibility to SLE. In this study, we performed a meta-analysis (including 43 studies) to evaluate the association between IFIH1… read more here.

Keywords: ifih1; stat pathway; sle; jak stat ... See more keywords
Photo by harrydona from unsplash

Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors

Sign Up to like & get
recommendations!
Published in 2021 at "Dermatology and Therapy"

DOI: 10.1007/s13555-021-00596-8

Abstract: Deucravacitinib, a novel, oral, selective inhibitor of tyrosine kinase 2 (TYK2) signaling, acts via an allosteric mechanism by binding to the enzyme’s regulatory domain instead of the catalytic domain. This unique binding provides high functional… read more here.

Keywords: jak; kinase; inhibition; tyk2 ... See more keywords
Photo by linsartistry from unsplash

Identification of a Novel 2,8-Diazaspiro[4.5]decan-1-one Derivative as a Potent and Selective Dual TYK2/JAK1 Inhibitor for the Treatment of Inflammatory Bowel Disease.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of medicinal chemistry"

DOI: 10.1021/acs.jmedchem.1c01137

Abstract: In this study, we described a series of 2,8-diazaspiro[4.5]decan-1-one derivatives as selective TYK2/JAK1 inhibitors. Systematic exploration of the structure-activity relationship through the introduction of spirocyclic scaffolds based on the reported selective TYK2 inhibitor 14l led… read more here.

Keywords: compound; tyk2; diazaspiro decan; inhibitor ... See more keywords
Photo from wikipedia

Catalytically Impaired TYK2 Variants are Protective Against Childhood- and Adult-Onset Systemic Lupus Erythematosus in Mexicans

Sign Up to like & get
recommendations!
Published in 2019 at "Scientific Reports"

DOI: 10.1038/s41598-019-48451-3

Abstract: Type I interferon (IFN-I) pathway plays a central role in the systemic lupus erythematosus (SLE) pathogenesis. Recent data suggest that SLE is associated with variants in IFN-I genes, such as tyrosine kinase 2 (TYK2), which… read more here.

Keywords: adult onset; childhood; systemic lupus; lupus erythematosus ... See more keywords
Photo from wikipedia

Selective TYK2 inhibitors as potential therapeutic agents: a patent review (2019–2021)

Sign Up to like & get
recommendations!
Published in 2022 at "Expert Opinion on Therapeutic Patents"

DOI: 10.1080/13543776.2022.2026927

Abstract: ABSTRACT Introduction Tyrosine kinase 2 (TYK2) is a member of the JAK family class of kinases that is responsible for mediating the immune response to IL-12, IL-23, and IFNα. The therapeutic value of targeting this… read more here.

Keywords: review; inhibitors potential; selective tyk2; tyk2 ... See more keywords
Photo from wikipedia

TYK2 inhibition: changing the treatment landscape for psoriasis?

Sign Up to like & get
recommendations!
Published in 2021 at "Expert Review of Clinical Immunology"

DOI: 10.1080/1744666x.2022.2008240

Abstract: Psoriasis is a common immune-mediated inflammatory disease affecting approximately 2% of individuals living in Western countries. Patients with psoriasis suffer from a multitude of comorbidities such as psoriatic arthritis, inflammatory bowel disease, anxiety and depression,… read more here.

Keywords: tyk2; psoriasis; deucravacitinib; poetyk pso ... See more keywords
Photo from wikipedia

Tyk2 is a tumor suppressor in colorectal cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Oncoimmunology"

DOI: 10.1080/2162402x.2022.2127271

Abstract: ABSTRACT Janus kinase Tyk2 is implicated in cancer immune surveillance, but its role in solid tumors is not well defined. We used Tyk2 knockout mice (Tyk2Δ/Δ) and mice with conditional deletion of Tyk2 in hematopoietic… read more here.

Keywords: tyk2; tyk2 iec; colorectal cancer; tumor ... See more keywords
Photo from wikipedia

Association of TYK2 polymorphisms with autoimmune diseases: A comprehensive and updated systematic review with meta-analysis

Sign Up to like & get
recommendations!
Published in 2021 at "Genetics and Molecular Biology"

DOI: 10.1590/1678-4685-gmb-2020-0425

Abstract: Abstract Autoimmune diseases are characterized by the loss of self-tolerance, leading to immune-mediated tissue destruction and chronic inflammation. Tyrosine kinase 2 (TYK2) protein plays a key role in immunity and apoptosis pathways. Studies have reported… read more here.

Keywords: autoimmune; tyk2; autoimmune diseases; meta analysis ... See more keywords
Photo from wikipedia

TYK2 in Immune Responses and Treatment of Psoriasis

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Inflammation Research"

DOI: 10.2147/jir.s380686

Abstract: Abstract Tyrosine kinase 2 (TYK2), a key part of the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, plays an integral role in the differentiation and immune responses of intrinsic immune cells and regulates… read more here.

Keywords: responses treatment; tyk2; treatment psoriasis; immune responses ... See more keywords
Photo by nightcrawler1986 from unsplash

112-OR: Critical Role of Tyrosine Kinase 2 (TYK2) in Human Pancreatic Differentiation

Sign Up to like & get
recommendations!
Published in 2019 at "Diabetes"

DOI: 10.2337/db19-112-or

Abstract: Type 1 diabetes (T1D) is caused by the autoimmune destruction of pancreatic beta cells. Genome wide association and fine mapping studies to identify causal variants predicted several loci in the human genome that are associated… read more here.

Keywords: differentiation; role; critical role; tyk2 ... See more keywords